mRNA expression and phenotype of odontogenic tumours in the v-Ha-ras transgenic mouse

Archives of Oral Biology

Volumn 48, Issue 12, 2003, Pages 843-850

  Dodds, A P ^a   Cannon, R E ^b   Suggs, C A ^a   Wright, J T ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Gene expression; Histology; Odontogenic tumours; v Ha ras

Indexed keywords

MURINAE; MUS MUSCULUS;

EID: 0242403080     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9969(03)00178-X     Document Type: Article

References (39)

1. Gardner DG. An orderly approach to the study of odontogenic tumors in animals. J Comp Pathol 1992;107:427-38.
2. Hoffman S, Jacoway JR, Krolls SO. Intraosseous and parosteal tumors of the jaws. In: Hartmann WH, Sobin LH, editors. Atlas of tumor pathology, vol. 24. Washington (DC): Armed Forces Institute of Pathology; 1987. p. 90-125.
3. Neville BW, Damm DD, Allen CM, Bouquot JE. Odontogenic cysts and tumors. In: Waldron CA, editor. Oral and maxillofacial pathology. Philadelphia (PA): W.B. Saunders Company; 1995. p. 493-538.
4. Becelli R, Carboni A, Cerulli G, Perugini M, Iannetti G. Mandibular ameloblastoma: analysis of surgical treatment carried out in 60 patients between 1977 and 1998. J Craniofac Surg 2002;13:395-400.
5. Ciment LM, Ciment AJ. Malignant ameloblastoma metastatic to the lungs 29 years after primary resection: a case report. Chest 2002;121:1359-61.
6. Ord RA, Blanchaert RHJ, Nikitakis NG, Sauk JJ. Ameloblastoma in children. J Oral Maxillofac Surg 2002;60:762-70.
7. Zwahlen RA, Gratz KW. Maxillary ameloblastomas: a review of the literature and of a 15-year database. J Craniomaxillofac Surg 2002;30:273-9.
8. Snead ML, Luo W, Hsu DD, Melrose RJ, Lau EC, Stenman G. Human ameloblastoma tumors express the amelogenin gene. Oral Surg Oral Med Oral Pathol 1992;74:64-72.
9. Cardiff RD, Leder A, Kuo A, Pattengale PK, Leder. Multiple tumor types appear in a transgenic mouse with the ras oncogene. Am J Pathol 1993;142:1199-1207.
10. Wright JT, Hansen L, Mahler J, Szczesniak C, Spalding JW. Odontogenic tumors in the v-Ha-ras (TG.AC) transgenic mouse. Arch Oral Biol 1995;40:631-8.
11. Leder A, Kuo A, Cardiff RD, Sinn E, Leder. v-Ha-ras transgene abrogates the initiation step in mouse skin tumorogenesis: effects of phorbol esters and retinoic acid. Proc Natl Acad Sci USA 1990;87:9178-9182.
12. Spalding JW, Momma J, Elwell MR, Tennant RW. Chemically induced skin carcinogenesis in a transgenic mouse line (TG.AC) carrying a v-Ha-ras gene. Carcinogenesis 1993;14: 1335-41.
13. Cannon RE, Spalding JW, Virgil KM, et al. Induction of the transgene expression in Tg.AC (v-Ha-ras) transgenic mice concomitant with DNA hypomethylation. Mol Carcinog 1998; 21:244-50.
14. Hansen L, Tennant RW. Follicular origin of epidermal papillomas in v-Ha-ras transgenic Tg.AC mouse skin. Proc Natl Acad Sci USA 1994;91:7822-6.
15. Hansen LA, Trempus CS, Mahler JF, Tennant RW. Association of tumor development with increased cellular proliferation and transgene overexpression, but not v-Ha-ras mutations, in v-Ha-ras transgenic Tg.AC mice. Carcinogenesis 1996;17: 1825-33.
16. Abiko Y, Murata M, Ito Y, et al. Immunohistochemical localization of amelogenin in human odontogenic tumors, using a polyclonal antibody against bovine amelogenin. Med Electron Microsc 2001;34:185-9.
17. Heikinheimo K, Jee KJ, Niini T, et al. Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray. J Dent Res 2002;81:525-30.
18. Dodds AP, Cox SA, Suggs CA, et al. Characterization and mRNA expression in an unusual odontogenic lesion in a patient with tricho-dento-osseous syndrome. Histol Histopathol 2003;18:849-54.
19. Takata T, Zhao M, Uchida T, et al. Immunohistochemical detection and distribution of enamelysin (MMP-20) in human odontogenic tumors. J Dent Res 2000;79:1608-13.
20. Bègue-Kirn C, Krebsbach PH, Bartlett JD, Butler WT. Dentin sialoprotein, dentin phosphoprotein, enamelysin and ameloblastin: tooth-specific molecules that are distinctively expressed during murine dental differentiation. Eur J Oral Sci 1998;106:963-70.
21. Hu JCC, Sun XL, Zhang CH, Liu SX, Bartlett JD, Simmer JP. Enamelysin and kallikrein-4 mRNA expression in developing mouse molars. Eur J Oral Sci 2002;110:307-15.
22. Deutsch D, Fermon E, Lustmann J, et al. Tuftelin mRNA is expressed in a human ameloblastoma tumor. Connect Tissue Res 1998;39:177-84.
23. Zhao ZY, Stock DW, Buchanan AV, Weiss KM. Expression of Dlx genes during the development of the murine dentition. Dev Genes Evol 2000;210:270-5.
24. Papagerakis P, Peuchmaur M, Hotton D, et al. Aberrant gene expression in epithelial cells of mixed odontogenic tumors. J Dent Res 1999;78:20-30.
25. Couwenhoven RI, Snead ML. Early determination and permissive expression of amelogenin transcription during mouse mandibular first molar development. Dev Biol 1994; 164:290-9.
26. Snead ML, Luo W, Lau EC, Slavkin HC. Spatial-and temporal-restricted pattern for amelogenin gene expression during mouse molar tooth organogenesis. Development 1988;104: 77-85.
27. Zeichner-David M, Diekwisch T, Fincham A, et al. Control of ameloblast differentiation. Int J Dev Biol 1995;39:69-92.
28. Fincham AG, Simmer JP. Amelogenin proteins of developing dental enamel. Ciba Found Symp 1997;205:118-30.
29. Zeichner-David M, Vo H, Tan H, et al. Timing of the expression of enamel gene products during mouse tooth development. Int J Dev Biol 1997;41:27-38.
30. Kumamoto H, Yoshida M, Ooya K. Immunohistochemical detection of amelogenin and cytokeratin 19 in epithelial odontogenic tumors. Oral Dis 2001;7:171-6.
31. Saku T, Okabe H, Shimokawa H. Immunohistochemical demonstration of enamel proteins in odontogenic tumors. J Oral Pathol Med 1992;21:113-9.
32. Bartlett JD, Ryu OH, Xue J, Simmer JP, Margolis HC. Enamelysin mRNA displays a developmentally defined pattern of expression and encodes a protein which degrades amelogenin. Connect Tissue Res 1998;39:101-9.
33. Caterina JJ, Skobe Z, Yanli Ding J-S, Simmer JP, Birkedal-Hansen H, Bartlett JD. Enamelysin (matrix Metalloproteinase 20)-deficient mice display an amelogenesis imperfecta phenotype. J Biol Chem 2002;277:49598-604.
34. Grigoriadis AE, Wang ZQ, Cecchini MG, et al. C-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 1994;266:443-8.
35. Greenhalgh DA, Welty DJ, Player A, Yuspa SH. Two oncogenes, v-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinoma. Proc Natl Acad Sci USA 1990;87:643-7.
36. Wang X-J, Greenhalgh DA, Roop DR. Transgenic coexpression of v-Ha-ras and transforming growth factor α increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation. Mol Carcinog 2000;27:200-9.
37. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001;11:372-7.
38. Åberg T, Wozney J, Thesleff I. Expression patterns of bone morphogenetic proteins (BMPs) in the developing mouse tooth suggest roles in morphogenesis and cell differentiation. Dev Dyn 1997;210:383-96.
39. Gao YH, Yang LJ, Yamaguchi A. Immunohistochemical demonstration of bone morphogenetic protein in odontogenic tumors. J Oral Pathol Med 1997;26:273-7.